Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
1.855.MyBioSource
Fax 1.858.633.0166    Email sales@mybiosource.com 
tel/fax
menu1 Home Products Ordering Company Help menu7
bottom
   MyBioSource  rightarrow Protein Family  rightarrow Immunoglobulin lambda variable  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Menu separator
separator
ELISA Kit ELISA Kit
CLIA Kit CLIA Kit
PCR Kit PCR Kit
Monoclonal Antibody Monoclonal Antibody
Polyclonal Antibody Polyclonal Antibody
Secondary Antibody Secondary Antibody
Antigen Antigen
Biochemical Biochemical
cDNA Clone cDNA Clone
siRNA siRNA
Peptide Peptide
Recombinant/Purified Protein Rec./Purified Protein

Custom ELISA Kit Custom ELISA Kit
Custom Protein Custom Protein
Custom Antibody Custom Antibody
Antibody Matched Pairs Antibody Matched Pairs
Antibody & Corresponding Blocking Peptide Pairs Antibody Peptide Pairs
Phospho-Specific Antibodies Phospho Antibodies
Products by Disease Products by Disease
Products by Pathway Products by Pathway
Products by Tissue Products by Tissue

arrow Advanced Search
arrow Submit Technical Q&A
arrow International Distributors
arrow Contact Us
separator
Our Best Sellers moreseparator
separator
 • Matrix Metalloproteinase 3 (MMP3) ELISA Kit
 • CCL4 Antibody
 • Serine-threonine-protein kinase BIK1 (BIK1) Recombinant Protein
 • ABCA8 Antibody
 • Npap60-Nup50 Antibody
 • Metapneumovirus Antibody
 • ABRACL Antibody
 • Collagen Type II Alpha 1 (COL2a1) ELISA Kit
 • Myeloperoxidase (MPO) Antibody
 • PKA-R2 beta Antibody
 • H1 (H1N1)(A-South Carolina-1-18) Antibody
 • 30S ribosomal protein S5 (rpsE) Recombinant Protein
 • Anti-Phospholipase A2 Antibody (PLA2) ELISA Kit
 • Adenomatous polyposis coli protein 2 (APC2) ELISA Kit
 downarrow more ...
separator

Immunoglobulin lambda variable

separator
V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition .

Below are the list of possible Immunoglobulin lambda variable products. If you cannot find the target and/or product is not available in our catalog, please click here to contact us and request the product or submit your request for custom elisa kit production, custom recombinant protein production or custom antibody production. Custom ELISA Kits, Recombinant Proteins and Antibodies can be designed, manufactured and produced according to the researcher's specifications.
 

Immunoglobulin lambda variable 1-40

 Immunoglobulin lambda variable 1-40 ELISA Kit
 Immunoglobulin lambda variable 1-40 Recombinant
 Immunoglobulin lambda variable 1-40 Antibody
Also known as Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM).
V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve a
>>>
s receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
 IGLV1-40 ELISA Kit
 IGLV1-40 Recombinant
 IGLV1-40 Antibody
Table BarTOPTable Bar
 

Immunoglobulin lambda variable 1-44

 Immunoglobulin lambda variable 1-44 ELISA Kit
 Immunoglobulin lambda variable 1-44 Recombinant
 Immunoglobulin lambda variable 1-44 Antibody
Also known as Immunoglobulin lambda variable 1-44 (Ig lambda chain V-I region MEM) (Ig lambda chain V-I region VOR).
V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membra
>>>
ne-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
 IGLV1-44 ELISA Kit
 IGLV1-44 Recombinant
 IGLV1-44 Antibody
Table BarTOPTable Bar
 

Immunoglobulin lambda variable 1-47

 Immunoglobulin lambda variable 1-47 ELISA Kit
 Immunoglobulin lambda variable 1-47 Recombinant
 Immunoglobulin lambda variable 1-47 Antibody
Also known as Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH).
V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membran
>>>
e-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
 IGLV1-47 ELISA Kit
 IGLV1-47 Recombinant
 IGLV1-47 Antibody
Table BarTOPTable Bar
 

Immunoglobulin lambda variable 1-51

 Immunoglobulin lambda variable 1-51 ELISA Kit
 Immunoglobulin lambda variable 1-51 Recombinant
 Immunoglobulin lambda variable 1-51 Antibody
Also known as Immunoglobulin lambda variable 1-51 (Ig lambda chain V-I region BL2) (Ig lambda chain V-I region EPS) (Ig lambda chain V-I region NEW) (Ig lambda chain V-I region NIG-64).
IGLV1-51: V segment of the variable region of immunoglobulins light chain that participates to the antigen recognition. Immunoglobulins (Igs), also known as antibodies, are membrane- bound or secreted glycoprote
>>>
ins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors which, upon binding of a specific antigen (Ag), trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable region of one heavy chain, together with that of its associated light chain. Thus, each Ig has two antigen binding sites with remarkable affinity for a particular antigen. The variable regions are assembled by a process called V(D)J recombination and can then be subjected to somatic hypermutation after exposure to antigen to allow affinity maturation for a particular Ag (PubMed:20176268, PubMed:17576170). {ECO:0000303|PubMed:17576170, ECO:0000303|PubMed:20176268, ECO:0000303|PubMed:22158414}. Immunoglobulins are composed of two identical heavy chains and two identical light chains, linked by disulfide bonds. {ECO:0000303|PubMed:20176268}
 IGLV1-51 ELISA Kit
 IGLV1-51 Recombinant
 IGLV1-51 Antibody
Table BarTOPTable Bar
 

Immunoglobulin lambda variable 2-11

 Immunoglobulin lambda variable 2-11 ELISA Kit
 Immunoglobulin lambda variable 2-11 Recombinant
 Immunoglobulin lambda variable 2-11 Antibody
Also known as Immunoglobulin lambda variable 2-11 (Ig gamma lambda chain V-II region DOT) (Ig lambda chain V-II region BOH) (Ig lambda chain V-II region BUR) (Ig lambda chain V-II region NIG-58) (Ig lambda chain V-II region TRO) (Ig lambda chain V-II region WIN).
V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also kn
>>>
own as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
 IGLV2-11 ELISA Kit
 IGLV2-11 Recombinant
 IGLV2-11 Antibody
Table BarTOPTable Bar
 

Immunoglobulin lambda variable 2-14

 Immunoglobulin lambda variable 2-14 ELISA Kit
 Immunoglobulin lambda variable 2-14 Recombinant
 Immunoglobulin lambda variable 2-14 Antibody
Also known as Immunoglobulin lambda variable 2-14 (Ig lambda chain V-II region NIG-84) (Ig lambda chain V-II region TOG) (Ig lambda chain V-II region VIL).
V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognitio
>>>
n phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
 IGLV2-14 ELISA Kit
 IGLV2-14 Recombinant
 IGLV2-14 Antibody
Table BarTOPTable Bar
 

Immunoglobulin lambda variable 2-23

 Immunoglobulin lambda variable 2-23 ELISA Kit
 Immunoglobulin lambda variable 2-23 Recombinant
 Immunoglobulin lambda variable 2-23 Antibody
Also known as Immunoglobulin lambda variable 2-23 (Ig lambda chain V-II region NEI).
V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve a
>>>
s receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
 IGLV2-23 ELISA Kit
 IGLV2-23 Recombinant
 IGLV2-23 Antibody
Table BarTOPTable Bar
 

Immunoglobulin lambda variable 2-8

 Immunoglobulin lambda variable 2-8 ELISA Kit
 Immunoglobulin lambda variable 2-8 Recombinant
 Immunoglobulin lambda variable 2-8 Antibody
Also known as Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC).
V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membra
>>>
ne-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
 IGLV2-8 ELISA Kit
 IGLV2-8 Recombinant
 IGLV2-8 Antibody
Table BarTOPTable Bar
 

Immunoglobulin lambda variable 3-1

 Immunoglobulin lambda variable 3-1 ELISA Kit
 Immunoglobulin lambda variable 3-1 Recombinant
 Immunoglobulin lambda variable 3-1 Antibody
Also known as Immunoglobulin lambda variable 3-1 (Ig lambda chain V-IV region Bau) (Ig lambda chain V-IV region MOL) (Ig lambda chain V-IV region X).
V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phas
>>>
e of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
 IGLV3-1 ELISA Kit
 IGLV3-1 Recombinant
 IGLV3-1 Antibody
Table BarTOPTable Bar
 

Immunoglobulin lambda variable 3-19

 Immunoglobulin lambda variable 3-19 ELISA Kit
 Immunoglobulin lambda variable 3-19 Recombinant
 Immunoglobulin lambda variable 3-19 Antibody
Also known as Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH).
V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve a
>>>
s receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
 IGLV3-19 ELISA Kit
 IGLV3-19 Recombinant
 IGLV3-19 Antibody
Table BarTOPTable Bar
 

Immunoglobulin lambda variable 3-21

 Immunoglobulin lambda variable 3-21 ELISA Kit
 Immunoglobulin lambda variable 3-21 Recombinant
 Immunoglobulin lambda variable 3-21 Antibody
Also known as Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT).
V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition
>>>
phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
 IGLV3-21 ELISA Kit
 IGLV3-21 Recombinant
 IGLV3-21 Antibody
Table BarTOPTable Bar
 

Immunoglobulin lambda variable 3-25

 Immunoglobulin lambda variable 3-25 ELISA Kit
 Immunoglobulin lambda variable 3-25 Recombinant
 Immunoglobulin lambda variable 3-25 Antibody
Also known as Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil).
V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve a
>>>
s receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
 IGLV3-25 ELISA Kit
 IGLV3-25 Recombinant
 IGLV3-25 Antibody
Table BarTOPTable Bar
 

Immunoglobulin lambda variable 3-27

 Immunoglobulin lambda variable 3-27 ELISA Kit
 Immunoglobulin lambda variable 3-27 Recombinant
 Immunoglobulin lambda variable 3-27 Antibody
Also known as Immunoglobulin lambda variable 3-27 (Ig lambda chain V-IV region Kern).
V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve
>>>
as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
 IGLV3-27 ELISA Kit
 IGLV3-27 Recombinant
 IGLV3-27 Antibody
Table BarTOPTable Bar
 

Immunoglobulin lambda variable 6-57

 Immunoglobulin lambda variable 6-57 ELISA Kit
 Immunoglobulin lambda variable 6-57 Recombinant
 Immunoglobulin lambda variable 6-57 Antibody
Also known as Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT).
V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also known as antibodies, are membrane-bound or
>>>
secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
 IGLV6-57 ELISA Kit
 IGLV6-57 Recombinant
 IGLV6-57 Antibody
Table BarTOPTable Bar
 

Immunoglobulin lambda variable 7-43

 Immunoglobulin lambda variable 7-43 ELISA Kit
 Immunoglobulin lambda variable 7-43 Recombinant
 Immunoglobulin lambda variable 7-43 Antibody
Also known as Immunoglobulin lambda variable 7-43 (Ig lambda chain V region 4A).
IGLV7-43: V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins s
>>>
erve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268). {ECO:0000303|PubMed:17576170, ECO:0000303|PubMed:20176268, ECO:0000303|PubMed:22158414}. Immunoglobulins are composed of two identical heavy chains and two identical light chains, linked by disulfide bonds. {ECO:0000303|PubMed:20176268}

Chromosomal Location of Human Ortholog: 22q11.2

Cellular Component: extracellular region; plasma membrane

Molecular Function: serine-type endopeptidase activity

Biological Process: complement activation; complement activation, classical pathway; receptor-mediated endocytosis; regulation of immune response
 IGLV7-43 ELISA Kit
 IGLV7-43 Recombinant
 IGLV7-43 Antibody
Table BarTOPTable Bar
Proteins Root Name Listing
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions